Healthcare -
Biotechnology - NASDAQ - US
$ 4.73
1.94 %
$ 402 M
Market Cap
-4.01
P/E
TERN - CHANGE IN WORKING CAPITAL
Change in Working Capital TERN - Terns Pharmaceuticals, Inc.
1.29 M
LAST VALUE
70.47%
2 YEAR CAGR
41.48%
5 YEAR CAGR
0.00%
10 YEAR CAGR